Need to set a new target of $200 billion for India’s bioeconomy: Kiran Mazumdar-Shaw, ET HealthWorld
New Delhi: India is on the cusp of a major breakthrough when it comes to scaling up this enormous bioeconomy. New opportunities in the era of synthetic biology, gene editing, personalised medicine, precision medicine, and digital healthcare, which is now getting into this very exciting realm of digital prognostics and predictive diagnostics, said Kiran Mazumdar-Shaw,…